Skip to content
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
Archyde

Archyde

  • News
  • World
  • Economy
  • Technology
  • Health
  • Entertainment
  • Sport

short stature

FDA Approves Once-Weekly Sogroya for Turner Syndrome in Children

FDA Approves Once-Weekly Sogroya for Turner Syndrome in Children

November 21, 2026 by Health Desk

The U.S. Food and Drug Administration approved somapacitan-beco (Sogroya, Novo Nordisk) on Thursday as the first once-weekly growth hormone for children with Turner syndrome, expanding a treatment option that cuts … Read More

Categories Health Tags Back Pain, Child, childhood, children, growth hormone, joint pain, kids, pain, pain management, Pediatrics, short stature

Recent Posts

  • Poco F9 Pro: Snapdragon 8 Elite Gen 5 V Matches Flagship CPU, Loses GPU Core, Bose Audio Shows No Advantage – Digitec
  • Carmelo Anthony Rebukes Marlon Humphrey Over Baltimore ‘Criminals’ Remark, Demands Presence Over Apologies
  • School Nurses Urge Measles Protocols as U.S. Cases Top 5,800, Elimination Status Lost
  • Colts Waive Daniel Jones After Trade Deadline Passes Without Deal
  • FDA Approves Once-Weekly Sogroya for Turner Syndrome in Children
  • Latest News
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Privacy Policy
  • Terms and Conditions
  • About Us
© 2026 Archyde — All Rights Reserved. Contact | Privacy Policy